- Home
- XOMA vs NTHI Comparison
XOMA vs NTHI Comparison
Compare XOMA & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMA
- NTHI
- Stock Information
- Founded
- XOMA 1981
- NTHI 2008
- Country
- XOMA United States
- NTHI United States
- Employees
- XOMA N/A
- NTHI N/A
- Industry
- XOMA Biotechnology: Pharmaceutical Preparations
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- XOMA Health Care
- NTHI Health Care
- Exchange
- XOMA Nasdaq
- NTHI Nasdaq
- Market Cap
- XOMA 250.1M
- NTHI 225.0M
- IPO Year
- XOMA N/A
- NTHI N/A
- Fundamental
- Price
- XOMA $19.30
- NTHI $11.26
- Analyst Decision
- XOMA Strong Buy
- NTHI
- Analyst Count
- XOMA 2
- NTHI 0
- Target Price
- XOMA $72.00
- NTHI N/A
- AVG Volume (30 Days)
- XOMA 30.1K
- NTHI 56.0K
- Earning Date
- XOMA 03-17-2025
- NTHI 01-01-0001
- Dividend Yield
- XOMA N/A
- NTHI N/A
- EPS Growth
- XOMA N/A
- NTHI N/A
- EPS
- XOMA N/A
- NTHI N/A
- Revenue
- XOMA $28,487,000.00
- NTHI $83,000.00
- Revenue This Year
- XOMA $29.60
- NTHI N/A
- Revenue Next Year
- XOMA $34.18
- NTHI N/A
- P/E Ratio
- XOMA N/A
- NTHI N/A
- Revenue Growth
- XOMA 498.72
- NTHI N/A
- 52 Week Low
- XOMA $19.12
- NTHI N/A
- 52 Week High
- XOMA $35.00
- NTHI N/A
- Technical
- Relative Strength Index (RSI)
- XOMA 27.79
- NTHI N/A
- Support Level
- XOMA $20.45
- NTHI N/A
- Resistance Level
- XOMA $21.45
- NTHI N/A
- Average True Range (ATR)
- XOMA 0.80
- NTHI 0.00
- MACD
- XOMA 0.05
- NTHI 0.00
- Stochastic Oscillator
- XOMA 6.49
- NTHI 0.00
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.